Jaya is a biopharmaceutical R&D leader and entrepreneur with over 20 years of product development experience involving therapeutic drugs, nanotechnology/drug delivery systems and medical device products. At C2CBio, Jaya provides drug development consulting to early stage companies and asset scouting and due diligence for venture investments. She was the head of drug delivery/nanotechnology unit at Onyx Pharmaceutical (acquired by Amgen Inc.). Prior to this, she cofounded and led product development at StemPar Sciences, a cancer therapeutics start-up. Previously, she was at Johnson and Johnson Pharmaceutical, Alza Corporation, Genentech Inc. and Cygnus Inc., where she has contributed to the advancement of multiple early and late stage product candidates in oncology, ophthalmology and other therapeutic areas. Jaya volunteers regularly at several of bay area non-profit educational forums. Bringing exciting programs to school children via YWIB is one of her strong passions.